Valuation: DIAGNOS Inc.

Market Cap 59.13M 41.5M 36.86M 34.47M 31.41M 4B 59.95M 417M 161M 2.03B 156M 152M 6.54B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 58.61M 41.13M 36.53M 34.16M 31.13M 3.96B 59.41M 413M 160M 2.02B 154M 151M 6.48B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
94.52%
Yield 2025 *
-
Yield 2026 -
1 day-1.04%
1 week-1.04%
Current month-1.04%
1 month-4.04%
3 months+90.00%
6 months+72.73%
Current year+26.67%
1 week 0.47
Extreme 0.47
0.5
1 month 0.42
Extreme 0.42
0.53
Current year 0.18
Extreme 0.175
0.53
1 year 0.18
Extreme 0.175
0.53
3 years 0.18
Extreme 0.175
0.57
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
28/8/26 Buy

Director

105,000 0.0872%
21/8/26 Option

Director

-100,000 0.0830%
21/8/26 Option

Director

100,000 0.0830%
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%-1.04%+58.33%-10.38% 41.5M
+2.59%-0.63%-21.25%+60.81% 213B
+3.10%-0.64%+0.42%+16.72% 195B
+1.07%-2.18%+61.71%+456.79% 125B
+0.72%+2.39%+48.34%+123.86% 121B
+15.78%+19.67%-12.89%-30.87% 127B
+1.19%-0.57%-28.80%-41.19% 77.98B
+0.44%+0.04%-27.08%-8.27% 57.69B
+1.66%-1.73%-35.37% - 48.85B
+1.67%+1.02%+19.75%+131.72% 44.08B
Average +0.44%+1.00%+6.32%+77.69% 100.8B
Weighted average by Cap. +0.46%+1.05%+2.79%+90.09%

Financials

2025 2026
Net sales 104K 72.84K 64.7K 60.5K 55.13K 7.01M 105K 732K 283K 3.57M 273K 268K 11.47M 65.48K 45.95K 40.81K 38.17K 34.78K 4.42M 66.38K 462K 179K 2.25M 173K 169K 7.24M
Net income -4.29M -3.01M -2.67M -2.5M -2.28M -290M -4.35M -30.23M -11.7M -147M -11.29M -11.05M -474M -4.56M -3.2M -2.84M -2.66M -2.42M -308M -4.62M -32.12M -12.43M -157M -12M -11.74M -503M
Net Debt -164K -115K -102K -95.42K -86.95K -11.06M -166K -1.15M -447K -5.63M -431K -422K -18.09M -525K -369K -327K -306K -279K -35.48M -532K -3.7M -1.43M -18.07M -1.38M -1.35M -58.04M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
01/10/26 CA$0.4750 -1.04% 252,810
30/09/26 CA$0.4800 -0.52% 209,508
29/09/26 CA$0.4825 +0.52% 306,500
28/09/26 CA$0.4800 -2.04% 186,040
25/09/26 CA$0.4900 +2.08% 415,089

Annual profits - Rate of surprise